| Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy. | |
| | |
MedLine Citation:
|
PMID: 22078636 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Although the clinical manifestations of type 2 diabetic nephropathy and decline in kidney function are similar to those in type 1, the clinical course and the renal structural changes are more heterogeneous in type 2 diabetic patients. Previous studies have shown that an increased urine IgM excretion in patients with type 1 diabetic nephropathy was associated with poor outcome. In the present follow-up study we examine the prognostic value of baseline urine IgM excretion in patients with type 2 diabetes mellitus. METHODS: A cohort of 106 (74 male and 32 female) patients with type 2 diabetes regularly attending our diabetes out-patient clinic at Skane University Hospital in Lund. They were recruited prospectively under the period between 1992 and 2004. Patients were followed-up until January 2009. The end point was cardiovascular (CV) death or end-stage renal disease (ESRD). The median follow-up time was 5 years (0.5-13 years). Participants were divided according to degree of albuminuria and IgM-uria. RESULTS: During follow-up time, 28 (19 male and 9 female) patients died of CV events and 41 (26 male and 15 female) developed ESRD. The risk of CV mortality was 2.4 fold, and the risk of renal failure 4.9 fold higher in patients with increased urine IgM excretion compared to patients with low urine IgM excretion. Stratified analysis showed that an increased urine IgM excretion was an independent predictor of renal and cardiovascular death irrespective of the degree of albuminuria (HR=3.6, 95% CI: 2.1-6.0, P<0.001). In conclusion, type 2 diabetic nephropathy patients with high urine IgM excretion rates carry an increased risk of renal and cardiovascular death. |
| | |
Authors:
|
Rafid Tofik; Ole Torffvit; Bengt Rippe; Omran Bakoush |
Related Documents
:
|
9392846 - Transport of insulin across the blood-brain barrier: saturability at euglycemic doses o... 7475976 - Cerebrospinal fluid corticotropin-releasing hormone in neurodegenerative diseases: redu... 11239956 - Increased anaerobic glycolysis in mitochondrial trifunctional protein-deficient brain. 1017836 - Blood glucose: how reliable an indicator of brain glucose? 1671006 - Susceptibility to type i diabetes in women is associated with the cd3 epsilon locus on ... 9392846 - Transport of insulin across the blood-brain barrier: saturability at euglycemic doses o... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-11-10 |
Journal Detail:
|
Title: Diabetes research and clinical practice Volume: - ISSN: 1872-8227 ISO Abbreviation: - Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8508335 Medline TA: Diabetes Res Clin Pract Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Department of Nephrology, Lund University, Lund, Sweden. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: IL-4 acts as a potent stimulator of IFN-? expression in CD8+ T cells through STAT6-dependent and ind...
Next Document: Health problems and disability in long-term sickness absence: ICF coding of medical cerificates.